◆ 会议时间：2020年6月17-20日 会议推迟至：2021年，请在下方进入2021年会议页面
◆ 会议地点：意大利 都灵(托里诺)Torino
◆ 会议改期：2021年欧洲癌症研究协会大会(EACR2021)
◆ 会议简介：
2020年第26届欧洲癌症研究协会(EACR)两年一届大会（创新的癌症科学）将于2020年6月17日至20日在意大利都灵举行。EACR2020是一个为期四天的涉及基础、临床前和转化癌症研究等广泛主题的会议，会议将重点展示最新的研究成果，并将癌症研究研究领域的人士聚集在一起，以激发创新，建立联系和合作。
欧洲癌症研究协会（EACR)成立于1968年，在全球101个国家拥有超过10000名会员，使命是“为了公众利益促进癌症研究：从基础研究到预防、治疗和护理”。EACR通过组织最高质量的科学会议，促进癌症研究者之间的沟通与协作。——未经本站许可，禁止复制转载镜像本站任何内容—领域国际医学会议网。
EACR 2020 has been postponed to June 2021
EACR 2020 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
关键日期-Key dates
Bursary application deadline : 24 February 2020
Abstract submission deadline : 02 March 2020
Early registration rate : 16 March 2020
Regular registration rate : 11 May 2020
Late registration rate : 12 June 2020
EACR2020 注册费：
EACR members
|
Early rate
by 16 March 2020 |
Regular rate
11 May 2020 |
Late rate
12 June 2020 |
On-site rate
after 12 June |
| EACR Member |
€525 |
€625 |
€775 |
€925 |
| EACR Early Career member(previously 'Young Investigator member') |
€450 |
€500 |
€550 |
€575 |
| EACR Student member |
€350 |
€400 |
€450 |
€475 |
Non-Member
| |
Early rate |
Regular rate |
Late rate |
On-site rate |
| Non-Member |
€675 |
€775 |
€925 |
€1075 |
| Student Non-Member* |
€400 |
€450 |
€525 |
€550 |
| Industry rate** |
€975 |
€1150 |
€1250 |
€1350 |
Day rates
| Day rate: only available onsite |
€350 |
*Approval of Student Non-Members: During the registration process Student Non-Members will need to upload a PDF letter from your Head of Department to confirm your student status.
** Industry rates apply to participants who work for a for-profit company and are funded to attend the meeting by that company
Prices include 22% Italian VAT, which will be automatically deducted for Italian VAT registered businesses.
◆ 参会对象：医生、药剂师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
